Xeris Pharmaceuticals | XERS - Ebit





Ebit Alterar Data
Celltrion KRW 20.08B 6.67B 2026-06
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -61.48M 14.95M 2026-06
Divis Laboratories Ltd INR 14.24B 2.95B 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Kangmei Pharma CNY -35.26M 22.54M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD 5.33M 15.12M 2026-06
Ovoca Bio EUR -173K 990K 2025-12
Pacira USD 2.57B 2.56B 2026-09
Perrigo USD 27.2M 116.6M 2026-09
Pharma Mar EUR 7.65M 9.06M 2026-09
Qiagen NV USD 141.4M 44.52M 2026-06
Sartorius EUR 179.8M 15.8M 2026-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -389M 318.05M 2026-03
Zz Pientze Pharmaceu CNY 222.81M 140.02M 2026-09